Tocilizumab in Methotrexate-Naïve Rheumatoid Arthritis – A Cost-Utility Model for Slovakia
Abstract
Authors
S Chang L Sawyer F Dejonckheere L Grichova A Diamantopoulos
S Chang L Sawyer F Dejonckheere L Grichova A Diamantopoulos
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now